• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉曲张硬化治疗后的长期生存及严重再出血

Long term survival and severe rebleeding after variceal sclerotherapy.

作者信息

Balanzó J, Such J, Sainz S, González D, Guarner C, Allende L, Lacalle J P, Vilardell F

机构信息

Escuela de Patologé Digestiva, Hospital Santa Creu i Sant Pau, Barcelona.

出版信息

Surg Gynecol Obstet. 1990 Dec;171(6):489-92.

PMID:2244282
Abstract

Of 197 consecutive patients with cirrhosis admitted because of bleeding from esophageal varices, 133 were included in a prospective study of elective sclerotherapy. We evaluated the incidence of extensive rebleeding and mortality rate. The period of study was 54 months and the mean follow-up period was 21 months. Forty-one patients had severe rebleeding and a majority of the episodes occurred during the first year. Only four patients had more than five sessions of sclerosis when rebleeding occurred. The probability rate for patients to be free of severe rebleeding after 48 months, according to Pugh's classification, was 88 per cent for those with grade A, 50 percent for grade B and 43 percent for grade C. The over-all mortality rate was 38.8 per cent (53 patients), with the highest rate noted during the first year. The mortality rate of patients with severe rebleeding was much higher than that of those who did not rebleed. Kaplan-Meier survival analysis at four years was 52 per cent, and survival rates in relation to Pugh's classification were 73 per cent for A, 53 per cent for B and 34 per cent for C. Differences between the three groups were statistically significant. Therefore, because of the high mortality rate associated with patients with cirrhosis and extensive rebleeding during the first year, it is important to achieve, as soon as possible, eradication of esophageal varices.

摘要

在197例因食管静脉曲张出血而入院的肝硬化患者中,133例被纳入择期硬化疗法的前瞻性研究。我们评估了广泛再出血的发生率和死亡率。研究期为54个月,平均随访期为21个月。41例患者发生严重再出血,且大多数发作发生在第一年。再出血发生时,只有4例患者接受了超过5次硬化治疗。根据Pugh分类,48个月后患者无严重再出血的概率,A级为88%,B级为50%,C级为43%。总死亡率为38.8%(53例患者),第一年死亡率最高。严重再出血患者的死亡率远高于未再出血患者。四年的Kaplan-Meier生存分析显示生存率为52%,与Pugh分类相关的生存率,A级为73%,B级为53%,C级为34%。三组之间的差异具有统计学意义。因此,由于肝硬化患者第一年与广泛再出血相关的高死亡率,尽快根除食管静脉曲张很重要。

相似文献

1
Long term survival and severe rebleeding after variceal sclerotherapy.静脉曲张硬化治疗后的长期生存及严重再出血
Surg Gynecol Obstet. 1990 Dec;171(6):489-92.
2
[Prognosis and prognostic factors of hemorrhage by rupture of varices in cirrhotic patients in the era of endoscopic sclerotherapy].[内镜硬化治疗时代肝硬化患者静脉曲张破裂出血的预后及预后因素]
Gastroenterol Clin Biol. 1991;15(11):838-44.
3
Prospective multicenter randomized trial comparing banding ligation with sclerotherapy of esophageal varices.比较食管静脉曲张套扎术与硬化疗法的前瞻性多中心随机试验。
Hepatogastroenterology. 1999 May-Jun;46(27):1769-73.
4
Sclerotherapy with or without octreotide for acute variceal bleeding.使用或不使用奥曲肽进行硬化治疗急性静脉曲张出血。
N Engl J Med. 1995 Aug 31;333(9):555-60. doi: 10.1056/NEJM199508313330904.
5
[Nadolol as an adjuvant to sclerotherapy of esophageal varices for prevention of recurrent hemorrhaging].纳多洛尔作为食管静脉曲张硬化治疗的辅助药物预防再出血
Rev Esp Enferm Dig. 1994 Jul;86(1):499-504.
6
Esophageal transection versus injection sclerotherapy in the management of bleeding esophageal varices in patients at high risk.食管横断术与注射硬化疗法治疗高危患者食管静脉曲张出血的比较
Surg Gynecol Obstet. 1985 Jun;160(6):539-46.
7
[Evaluation of 2 years' experience with elective endoscopic sclerotherapy of hemorrhagic esophageal varices in cirrhotic patients].[肝硬化患者出血性食管静脉曲张选择性内镜硬化治疗2年经验评估]
Gastroenterol Clin Biol. 1985 Nov;9(11):809-13.
8
The long-term morbidity and mortality rate in a cohort of patients with liver cirrhosis and oesophageal varices.一组肝硬化和食管静脉曲张患者的长期发病率和死亡率。
Hepatogastroenterology. 1995 Nov-Dec;42(6):979-84.
9
Endoscopic injection sclerotherapy of bleeding oesophageal varices: a retrospective analysis.内镜下注射硬化剂治疗食管静脉曲张出血:一项回顾性分析。
Ethiop Med J. 1997 Jan;35(1):13-22.
10
Experience in sclerotherapy for esophagogastric variceal bleeding.食管胃静脉曲张破裂出血硬化治疗的经验
Chin Med J (Engl). 2002 Jun;115(6):919-22.

引用本文的文献

1
Predictive role of serum procollagen III peptide and Knodell's index in survival prognosis of patients with hepatitis B virus liver cirrhosis.血清Ⅲ型前胶原肽和Knodell指数对乙型肝炎病毒肝硬化患者生存预后的预测作用
Wien Klin Wochenschr. 2003 May 15;115(9):302-8. doi: 10.1007/BF03040336.
2
Sclerotherapy versus sclerotherapy and propranolol in the prevention of rebleeding from oesophageal varices: a randomised study.硬化疗法与硬化疗法联合普萘洛尔预防食管静脉曲张再出血的随机对照研究
Gut. 1996 May;38(5):770-4. doi: 10.1136/gut.38.5.770.